Memscap shares rose sharply on the Paris Bourse on Wednesday, buoyed by a note from Euroland, which highlighted the "broad and innovative" offering of the MEMS specialist.
Around 12:30 pm, the share price climbed 8.5%, one of the biggest gains on the Paris market.
In a note published in the morning, Euroland considers that the French MEMS leader has "first-rate" industrial facilities and "substantial" production capacities, which should enable it to successfully implement its strategic plan.
The stockbroker expects sales to grow at an average annual rate of 26.2% between 2022 and 2025.
"At the current price, Memscap is paying 4.7x ROC 2023e vs. 10.5x on average for its comparables", adds Euroland.
Such a discount is not justified for this player, which is expected to combine sustained organic growth with high profitability", continues the Paris-based company.
In this context, Euroland initiates coverage of the stock at 'buy', with a price target of 4.15 euros.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Memscap is the leader in designing, manufacturing and marketing components, modules, systems and solutions based on micro electro-mechanical systems (MEMS). MEMS combine semiconductor micro-electronics with micro-manufacturing technology to make entire systems contained on one chip. Net sales (excluding sold businesses) break down by area of activity as follows:
- avionics and medical (88%): design and manufacture of multifunctional sensors and measurement systems for aeronautics and medical sectors;
- optical communications (11.1%): design and marketing of variable optical attenuators (VOAs) for the communications market, based on a fabless organization;
- dermocosmetics (0.9%): operation and management of the Group's assets in the dermatology and cosmetology sectors, primarily the Ioma brand.
Net sales are distributed geographically as follows: Europe (52.9%), the United States (38.5%), Asia (7.8%) and other (0.8%).